Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06674109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial

Study acronym: SAVE-Care
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: May 28, 2026 to Jul 1, 2026 Primary completion date: Feb 28, 2028 to Feb 1, 2028 · Collaborators expanded, about 10 wordsv6 Show 2 more changesShow less
    • Primary completion date: Feb 28, 2028 to Feb 1, 2028
    • Collaborators expanded, about 10 words

    See this version in full on ClinicalTrials.gov ↗

  2. Recruitment opened Study sites: 0 to 1 · Start date changed from estimate of Apr 30, 2026 to May 28, 2026v5 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 30, 2026 to May 28, 2026
  3. Primary and study completion dates: Mar 2, 2026 to Feb 28, 2028 Start date: Oct 15, 2025 to Apr 30, 2026v4 Show 1 more changeShow less
    • Start date: Oct 15, 2025 to Apr 30, 2026
  4. Start date: Dec 2, 2024 to Oct 15, 2025v3
  5. Study title revisedv2 See this version in full on ClinicalTrials.gov ↗
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
SAVE-Care (Sodium Glucose Cotransporter-2 inhibitors \[SGLT2i\] As Novel Gout Care) Trial is a double-blind randomized placebo-controlled trial (RCT) designed to assess the effect of empagliflozin on serum urate \[SU\] levels of gout patients, as well as levels of highly-sensitivity C-reactive protein \[hsCRP\] and interleukin 6 \[IL-6\], and estimate gout flares over 3 months, in order to develop a full-scale RCT of clinical endpoints to directly inform gout care guidelines.
Trial Details
NCT Number NCT06674109
Lead Sponsor Massachusetts General Hospital
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions Gout and Hyperuricemia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov